China's Market Approval Policy and Medical Insurance Payment System for Rare Disease
Related Insights
Blog
Accelerating Delivery and Patient Access to Rare Disease Treatments – Highlights from World Orphan Drug Congress
May 2, 2024
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Whitepaper
Overview of China's Market Approval Policy Med Insurance Payment System
Apr 7, 2022
Blog
Unpacking NICE’s review of the HST routing criteria: implications for manufacturers
Oct 3, 2024
Blog
Using Managed Entry Agreements to address JCA-era uncertainties
May 13, 2025
Blog
Early Scientific Advice in cost effectiveness markets – how to navigate it and is it worth it?
Jun 14, 2023
Blog
Celebrating 40 Years of Rare Disease Progress: WODC Highlights
Jun 6, 2023
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Whitepaper
The Chinese Pharmaceutical Market: Size, R&D, Regulations, Market Access and Innovations
Mar 9, 2023
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Playbook
Are you using real-world evidence?
Feb 1, 2023
Blog
U.S. price reforms 2022: How can drug manufacturers best prepare for the Inflation Reduction Act?
Aug 17, 2022
Related Insights
Blog
Accelerating Delivery and Patient Access to Rare Disease Treatments – Highlights from World Orphan Drug Congress
May 2, 2024
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Whitepaper
Overview of China's Market Approval Policy Med Insurance Payment System
Apr 7, 2022
Blog
Unpacking NICE’s review of the HST routing criteria: implications for manufacturers
Oct 3, 2024
Blog
Using Managed Entry Agreements to address JCA-era uncertainties
May 13, 2025
Blog
Early Scientific Advice in cost effectiveness markets – how to navigate it and is it worth it?
Jun 14, 2023
Blog
Celebrating 40 Years of Rare Disease Progress: WODC Highlights
Jun 6, 2023
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Whitepaper
The Chinese Pharmaceutical Market: Size, R&D, Regulations, Market Access and Innovations
Mar 9, 2023
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Playbook
Are you using real-world evidence?
Feb 1, 2023
Blog
U.S. price reforms 2022: How can drug manufacturers best prepare for the Inflation Reduction Act?
Aug 17, 2022